ACOR
Acorda Therapeutics, Inc.
NasdaqGS
People also watch:ALNYAMAGACADMDVNBMRN
24.95-1.76 (-6.59%)

After hours: 24.950.00 (0.00%) as of 4:56 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close26.71
Open25.29
Bid24.10 x 100
Ask26.00 x 200
52wk Range23.85 - 43.63
Day's Range24.00 - 26.20
Volume882,838
Avg Vol (3m)538,106
As of 4:00 PM EDT. Market closed.
  • Associated Press12 hours ago

    Acorda reports 2Q loss

    On a per-share basis, the Ardsley, New York-based company said it had a loss of 40 cents. Earnings, adjusted for costs related to mergers and acquisitions and stock option expense, were 7 cents per share. ...

  • Barrons.com2 days ago

    [$$] Three Biotech Q2 Reports Hold Potential

    Guggenheim Securities Acorda Therapeutics, Alkermes and Alexion Pharmaceuticals report second-quarter earnings on Thursday, July 28, before the market opens. We suspect Acorda (ticker: ACOR) (rated at ...